|
Post by trenddiver on Nov 16, 2015 2:38:23 GMT -5
9. Senior management should show their commitment to the company by buying shares in the open market. If management, with all the non-public information in front of them, were to purchase shares in the open market at these low prices it would be a major blow to the short interests and would encourage buying by many longs sitting on the fence.
Trend
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Nov 16, 2015 6:03:52 GMT -5
9. Senior management should show their commitment to the company by buying shares in the open market. If management, with all the non-public information in front of them, were to purchase shares in the open market at these low prices it would be a major blow to the short interests and would encourage buying by many longs sitting on the fence. Trend This is tricky... Unfortunately they cannot when they have non public information... There are really laws against it
|
|
|
Post by turk74 on Nov 16, 2015 8:44:00 GMT -5
Also, there's nothing "hidden". All is on the 10Q. Actually, what is not apparent from the MNKD 10Q, among other things, is just what Sanofi is spending the cash on to generate the substantial loss that MNKD is borrowing to support its portion of. The income statement for the JV is kept by SNY and only the portion of the loss incurred by the JV is reported in the MNKD 10Q. Perhaps this is all legit, but I question what SNY has accounted for over the last 9-12 months to generate a $120 million loss for the JV. Advertising - I don't think so. Discounts and coupons? Salaries for management and a sales force? A trade show presence?
|
|
|
Post by mssciguy on Nov 16, 2015 9:27:45 GMT -5
|
|
|
Post by trenddiver on Nov 16, 2015 9:48:26 GMT -5
9. Senior management should show their commitment to the company by buying shares in the open market. If management, with all the non-public information in front of them, were to purchase shares in the open market at these low prices it would be a major blow to the short interests and would encourage buying by many longs sitting on the fence. Trend This is tricky... Unfortunately they cannot when they have non public information... There are really laws against it Well insiders can certainly buy shares if they believe the company is undervalued.
|
|
|
Post by prosper on Nov 16, 2015 9:52:56 GMT -5
The only important thing to change right now is much stronger effort to get the insurance situation right. I am sure mgt is working as hard as they can on the other points. The additional information we need is why SNY with all its world wide presence has not filed applications in more countries and when they plan to do so.
|
|
|
Post by jpg on Nov 16, 2015 10:15:02 GMT -5
Informing us as to what is going on with the Israeli deal and finances at large would certainly be 'nice and shareholder friendly'. The deal was supposed to be closed yesterday? Why no update? Did the Deal go through? How much was raised? Isn't all of this material?
I'm maybe looking for an excuse to buy but they don't seem to want to help out with this...
|
|
|
Post by rrtzmd on Nov 16, 2015 10:52:41 GMT -5
For your information, I have just added a number 8 to my original post. 8. Have someone (Al Mann, Hakan, Matt or some Afrezza uses like Sam, etc.) appear in popular shows/reports like The Oprah Winfrey Show, 60 minutes, etc.
Sanofi and Mannkind should line up with some popular shows/reports like The Oprah Winfrey Show, 60 minutes, etc. Need not be too fancy or too promotional. Just need to reveal to the world that we have this new weapon to fight against diabetes. It would be great if Al Mann himself can do it. But Hakan, Matt or some Afrezza uses like Sam will also do a great job. Just demonstrate the dreamboat and breathe a couple time would be great. I do not think this will be that expensive and this will increase the awareness of Afrezza greatly. And I think Sanofi and Mannkind will be to line up such appearances if they take this seriously. Please stop. Respectfully, you have no idea what management is doing and your suggestions are not helping. Let them do their jobs, please. Just because you might own some shares does not give you the right to think that top management have nothing better to do than picking up your calls. Please stop. There is much more going on of which you have no idea. Shareholders will be informed when there is proper news to be announced. Thank you. "Just because you might own some shares does not give you the right to think that top management have nothing better to do than picking up your calls..." I beg your pardon but being a CEO or CFO does not translate into assuming the powers of an autocrat free of criticism and free of any responsibilities to the peasants -- aka shareholders! As a shareholder, it is your equity at stake whether you own a hundred shares or a hundred million shares. Any shareholder is well within rights to complain about anything seen fit. Also well within rights is filing suit and seeking damages if management has not lived up to its fiduciary responsibilities.
|
|
|
Post by jeremg on Nov 16, 2015 10:52:58 GMT -5
I'd very much like to know what was concluded to raise capital........... we can't have these days bleeding 7%, or it won't be long now. I was also under the impression the Indexes needed to purchase their shares as of yesterday which seems to fall in line with the volume we saw Thursday last week so I wouldn't expect anything further there. We need a press release with some encouraging information to stop the bleeding, bottom line.
|
|
|
Post by rrtzmd on Nov 16, 2015 11:02:48 GMT -5
I believe there are really only a couple of truly substantive issues at this point:
1. What is planned as regards the spirometry problem? So far, MNKD management has reassured that SNY is working on it but has provided no details that I could find as to what is being done or how successful it has been.
2. What is planned to address the third party payor problem? Will SNY lower the price of afrezza to meet the competitors' prices? Will they initiate a suitable trial to assess prove afrezza deserves a better label? When? How long will it take?
Without answers to those first, it doesn't hardly seem worth the effort to discuss anything else.
|
|
|
Post by compound26 on Nov 16, 2015 11:05:38 GMT -5
9. Senior management should show their commitment to the company by buying shares in the open market. If management, with all the non-public information in front of them, were to purchase shares in the open market at these low prices it would be a major blow to the short interests and would encourage buying by many longs sitting on the fence. Trend Trend, thanks for the suggestion. I have added your suggestion to my original post.
|
|
|
Post by cathode on Nov 16, 2015 11:11:44 GMT -5
Informing us as to what is going on with the Israeli deal and finances at large would certainly be 'nice and shareholder friendly'. The deal was supposed to be closed yesterday? Why no update? Did the Deal go through? How much was raised? Isn't all of this material?I'm maybe looking for an excuse to buy but they don't seem to want to help out with this... The deal between MNKD and TASE Indexes was closed on November 12, as described in the press release issued on the 12th. TASE indexes bought ~13.85M shares direct from MNKD raising ~$36.2M in capital for the company. The further dealings of the TASE indexes to acquire the shares they have to hold are not the concerns of MNKD. Whether MNKD has used their ATM to sell shares on the market will not be disclosed until the next quarterly report.
|
|
|
Post by bradleysbest on Nov 16, 2015 11:16:37 GMT -5
The waiting game continues....
|
|
|
Post by jpg on Nov 16, 2015 11:42:06 GMT -5
Informing us as to what is going on with the Israeli deal and finances at large would certainly be 'nice and shareholder friendly'. The deal was supposed to be closed yesterday? Why no update? Did the Deal go through? How much was raised? Isn't all of this material?I'm maybe looking for an excuse to buy but they don't seem to want to help out with this... The deal between MNKD and TASE Indexes was closed on November 12, as described in the press release issued on the 12th. TASE indexes bought ~13.85M shares direct from MNKD raising ~$36.2M in capital for the company. The further dealings of the TASE indexes to acquire the shares they have to hold are not the concerns of MNKD. Whether MNKD has used their ATM to sell shares on the market will not be disclosed until the next quarterly report. Mannkind will not inform shareholders of a materially significant thing like being financially solvent vs not? Sadly you are probably right. Very sad...
|
|
|
Post by derek2 on Nov 16, 2015 11:55:16 GMT -5
Actually, to robsacher's point, I find it really odd that MNKD does not have, and has not had, a corporate communications department or prime contact who is the single point of communications. It's kind of strange that Matt fills that role - it seems a poor use of an executive earning over $1M per year to be fielding calls and emails from the public. If even 5% of his time - 24 minutes per standard workday, was taken up by communications to retail investors, it would more than pay for a mid-level corporate communications lead. Same goes for investor conferences.
|
|